MedX Health Announces Change in Financing

    Funding to Support US and International Distributor Agreements Remains

    MISSISSAUGA, ON, July 16 /CNW/ - MedX Health Corp. (TSXV: MDX) ("MedX" or
the "Company") today announced that it has discontinued its financing
relationship with Research Capital, the firm that had begun their second round
of financing in May 2008. The low level laser therapy device manufacturer
continues to seek funding to help achieve the original goal of expanding its
commercialization plans.
    "We plan to efficiently close out this next round of financing as we
continue to grow our product line and business opportunities." said Steve
Guillen, president & chief executive officer. "The recently announced
distribution partnerships with Technology4Medicine, along with our recent
expansion internationally via a new network of worldwide distributors, are
evidence of our commitment to become a global leader in low level laser
therapy," said Mr. Guillen.

    About MedX Health Corp.

    MedX is a leading North American developer and manufacturer of low level
laser medical devices, including dental, rehabilitation and wound care
products. MedX is the world's only company focusing on developing and
delivering a broad cross-section of technologies and products involved in
healing using light therapy. MedX is committed to advocating for and bringing
the non-invasive, drug-free healing nature of light to people seeking relief
from pain and other physical ailments.
    MedX's strategy is to build upon its success in bringing relief of
symptoms in a non-pharmacologic manner in the rehabilitation market through
key partnerships, acquisitions, strong patent protection as well as developing
and commercializing advanced products in the dental and wound-care markets
that will position the company to increase revenue. In addition, MedX plans to
accelerate the development of a new product aimed at the rapidly-growing wound
care market: its "Photobandage", a bandage technology that allows a wound to
be bathed in light, designed to enhance the healing process. The Company
intends to license this new technology to one or more major wound care
companies for further development of marketing and sales.

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this press release.

    This press release contains "forward-looking information" within the
meaning of applicable Canadian securities legislation. Such forward-looking
information may include statements regarding the Company's future plans,
objectives, performance, growth, profits, operating expenses or its underlying
assumptions. Generally, forward-looking information can be identified by the
use of forward-looking terminology such as "plans", "expects", or "does not
expect", "is expected", "budget", "scheduled", "estimates", "forecasts",
"intends", "anticipates", or "does not anticipate", or "believes" or
variations of such words and phrases or state that certain actions, events or
results "may", "could", "would", "might", or "will be taken", "occur", or "be
achieved". Forward-looking information is subject to known and unknown risks,
uncertainties and other factors that may cause the actual results, level of
activity, performance or achievements of MedX to be materially different from
those expressed or implied by such forward-looking information, including
uncertainty of successful development of new products, uncertainty of
successful manufacturing or marketing of products, uncertainty of commercial
acceptance of products, uncertainty concerning governmental regulation,
dependency on key employees and relationships, rapid technological changes,
foreign currency fluctuations. MedX does not undertake to update any
forward-looking information, except in accordance with applicable securities

    %SEDAR: 00017466E

For further information:

For further information: Steve Guillen, President & Chief Executive
Officer, MedX Health Corp., Phone: (905) 826-0766, Email:; Nelson Smith, Taddle Creek Capital, Phone: (416)
565-7518, Email:

Organization Profile

MedX Health Corp.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890